Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Exercise Intolerance in Patients with HFpEF

Circulation; ePub 2017 Oct 9; Houstis, et al

Exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF) is undermined by multiple defects, including reductions in cardiac output and skeletal muscle diffusion capacity, a recent study found. The mechanism of exercise intolerance in each of 134 patients (n= 79 with HFpEF; n=55 controls) was examined. Cardiopulmonary exercise testing (CPET) with invasive monitoring was performed to measure hemodynamics, blood gases, and gas exchange during exercise in order to quantify 6 steps of oxygen transport and utilization and to identify the defective steps that hinder exercise capacity (peak VO2). Researchers found:

  • Peak VO2 was reduced by 34%±2% in HFpEF compared with controls of comparable age, gender, and body mass index (BMI).
  • 97% of HFpEF patients concealed defects at multiple steps of the O2 pathway.
  • Cardiac output and skeletal muscle O2 diffusion were impaired relative to controls by an average of 27±3% and 36±2%, respectively.
  • Correcting a patient’s cardiac output led to a 7±0.5% predicted improvement in exercise intolerance.
  • At the individual level, the impact of any given O2 pathway defect on a patient’s exercise capacity was strongly influenced by comorbid defects.

Citation:

Houstis NE, Eisman AS, Pappagianopoulos PP, et al. Exercise intolerance in HFpEF: Diagnosing and ranking its causes using personalized O2 pathway analysis. [Published online ahead of print October 9, 2017]. Circulation. doi:10.1161/CIRCULATIONAHA.117.029058.